$60 Million Paid By GlaxoSmithKline To Settle Lawsuits Over Drug Avandia


Bloomberg Business Week reports the largest drug maker in the U.K., GlaxoSmithKline (Glaxo), has agreed to pay $60 million in the first settlements of lawsuits over their drug, Avandia. This diabetes drug has been cited as causing heart attacks and strokes in some of the users.


Comments are closed.

Contact Information